etanidazole has been researched along with Body Weight in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The plasma half-life was 11." | 2.70 | Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles. ( Covey, JM; Evans, SM; Hahn, SM; Koch, CJ; McKenna, WG; Rockwell, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, CJ | 1 |
| Hahn, SM | 1 |
| Rockwell, K | 1 |
| Covey, JM | 1 |
| McKenna, WG | 1 |
| Evans, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study to Characterize the HRHV Axis in the Microenvironment of Breast Cancers[NCT01055678] | Early Phase 1 | 0 participants (Actual) | Interventional | 2010-01-31 | Withdrawn (stopped due to PI left Duke) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for etanidazole and Body Weight
| Article | Year |
|---|---|
Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.
Topics: Area Under Curve; Body Weight; Chromatography, High Pressure Liquid; Etanidazole; Half-Life; Humans; | 2001 |